SuperworthNovanta NOVT
- Market cap
- $5.3B
- PE
- 90.3×
- 10y median 78.6×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 5.2×
- EV/EBIT
- 48.2×
- Revenue, 12 months
- $1B
- +8% on a year ago
- Net margin
- 6.0%
- Free cash flow yield
- 2.1%
Novanta trades at 90.3× trailing earnings, pricier than 68% of the last ten years. Revenue was $1B over the last twelve months, up 8% on a year earlier with a 6% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $221.5M−1% | $211.6M−3% | $230.9M+5% | $235.9M+3% | $244.4M+10% | $238.1M+13% | $233.4M+1% | $241M+2% | $247.8M+1% | $258.3M+9% | $257.7M+10% | $265.8M+10% | |
| Cost of revenue | $119.9M−4% | $115M−7% | $130.5M+7% | $132.2M+6% | $135.2M+13% | $129.8M+13% | $129M−1% | $134.3M+2% | $136.9M+1% | $145.1M+12% | $144.1M+12% | $144.9M+8% |
| Gross profit | $101.6M+3% | $96.6M+2% | $100.4M+3% | $103.7M−0% | $109.2M+8% | $108.2M+12% | $104.4M+4% | $106.7M+3% | $110.9M+2% | $113.3M+5% | $113.6M+9% | $120.9M+13% |
| R&D | $22M+3% | $23.5M+7% | $23.2M+2% | $23.7M+2% | $23.3M+6% | $25.3M+8% | $23.2M+0% | $25.3M+7% | $24.1M+4% | $22.9M−10% | $23.3M+0% | $24M−5% |
| SG&A | $39.6M−2% | $41.7M+8% | $43.5M+6% | $44.8M+6% | $44.3M+12% | $43.3M+4% | $45.6M+5% | $47.1M+5% | $51.4M+16% | $51.6M+19% | $54.4M+19% | $60M+27% |
| $30.3M+6% | $21.7M−19% | $25.6M−3% | $25.7M−20% | $32.6M+7% | $26.7M+23% | $32.4M+27% | $14.9M−42% | $21.8M−33% | $24.8M−7% | $27.5M−15% | $18.1M+21% | |
| Interest expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pre-tax income | $23M−14% | $15.7M−17% | $16.9M−14% | $17.1M−32% | $24.2M+5% | $20.8M+32% | $26.4M+56% | $5.8M−66% | $15.8M−35% | $21.7M+4% | $26.4M−0% | $15.9M+175% |
| $1.8M−59% | $3.2M−12% | $2.2M+52% | $3.4M−23% | $5M+184% | $4.3M+34% | $5.2M+133% | $1.3M−62% | $5.1M+1% | $4.2M−3% | $5.3M+1% | $3.4M+160% | |
| Net income | $21.2M−6% | $12.5M−18% | $14.7M−20% | $13.8M−34% | $19.2M−10% | $16.5M+32% | $21.2M+45% | $4.5M−67% | $10.7M−45% | $17.5M+6% | $21.1M−1% | $12.5M+179% |
| $0.59−6% | $0.35−17% | $0.41−20% | $0.38−35% | $0.53−10% | $0.46+31% | $0.59+44% | $0.12−68% | $0.30−43% | $0.45−2% | $0.51−14% | $0.30+150% | |
| 36M+0% | 36.1M+0% | 36.1M+0% | 36.1M+0% | 36.1M+0% | 36.1M+0% | 36.1M+0% | 36.1M+0% | 36M−0% | 38.4M+6% | 41.2M+14% | 41.2M+14% |
Revenue: Q1 FY10: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY10: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY10: 6 months less the 3 months printed beside them.
R&D: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
SG&A: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Operating income: Q1 FY10: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY10: 6 months less the 3 months printed beside them.
Income tax: Q1 FY10: 6 months less the 3 months printed beside them.
Net income: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
EPS, diluted: 14 periods, Q1 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY10: share-days: the 6-month average less the second quarter's. 14 periods, Q4 FY11 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY14: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Industrial - Machinery nearest Novanta's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| NOVTNovanta | $5.3B | 90.3× | 78.6× | 5.2× | +8% | 6.0% | |
| POWLPowell Industries | $5.5B | 29.0× | 26.9× | 4.8× | +7% | 16.5% | |
| JBTMJBT MAREL | $5.6B | 29.5× | 31.4× | 1.4× | +45% | 4.9% | |
| AAONAaon | $5.7B | 35.9× | 45.9× | 2.9× | +54% | 8.2% | |
| TEXTerex | $5.9B | 26.2× | 17.5× | 0.9× | +29% | 2.2% | |
| ENSEnerSys | $6B | 17.8× | 20.2× | 1.6× | +4% | 9.3% | |
| GTESGates Industrial | $6.3B | 17.8× | 19.0× | 1.8× | +3% | 10.4% | |
| ALHAlliance Laundry | $4.2B | 23.4× | 23.7× | 2.4× | +10% | 10.1% | |
| ESABESAB | $4.2B | 22.4× | 25.3× | 1.4× | +10% | 5.7% | |
| TKRTimken | $7.6B | 29.6× | 15.4× | 1.6× | +5% | 5.4% | |
| MIRMirion Technologies | $3.7B | 165× | 189× | 3.6× | +16% | 2.4% | |
| Peer median | $5.7B | 27.6× | 24.5× | 1.7× | +10% | 7.0% |
Investors who own it
Investors we follow who held Novanta at the end of Jun 30, 2026, from their 13F filings.
- Ron BaronBaron Capital0.2% of portfoliotrimmed
- Polen CapitalPolen Capital0.0% of portfolionew
More on Novanta
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Industrial - Machinery
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .